James from SydneyParticipant
- August 15, 2010 at 12:27 pm
Sorry to hear your news, . IL2 was used in Oz but most Doctors have dropped it due as the side effects can be quite severe. In the US they administer the IL2 in an ICU environment. Australia does not seem to have that support set up to look after the patients. I expect its a cost issue.
Ippilimumab is probably the most promising thing out there although as someone else suggested MEK or NRAS drugs are worth asking about so maybe they could check to see if you have the necessary mutations.